US Bankruptcy Judge Sean Lane said Friday he will approve Purdue’s restructuring plan, which requires members of the Sackler ...
“The program itself saved my life,” he says. “Without a doubt (if not for the program) I’m sure I would be dead … The ...
1d
Purdue Pharma’s deal means money for some victims, end of Purdue company name. Here’s what to know
OxyContin maker Purdue Pharma's efforts to settle thousands of lawsuits over the toll of opioids is on the verge of approval.
The Food and Drug Administration has not approved 7-OH for any medical use, and it is not lawful as a dietary supplement or when added to conventional foods. The FDA is taking steps to classify 7-OH ...
Hundreds of people are on a waitlist for opioid addiction treatment in Los Angeles County jails as the state presses the ...
A federal bankruptcy judge said he will approve Purdue Pharma’s revised $7 billion opioid settlement, a deal that would require the Sackler family to give up ownership of the company and contribute ...
A federal bankruptcy court judge on Friday said he will approve OxyContin-maker Purdue Pharma’s latest deal to settle ...
Under the plan, the company will dissolve and its owners, members of the Sackler family, will pay as much as $7 billion of ...
Study finds adults on very-high opioid doses (>150 MME/wk) before abrupt discontinuation of long-term opioid therapy (LTOT) had >2x risk of suicide.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback